36 related articles for article (PubMed ID: 30776144)
1. NR1I2 genetic polymorphisms and the risk of anti-tuberculosis drug-induced hepatotoxicity: A systematic review and meta-analysis.
Yang M; Qiu Y; Jin Y; Liu W; Wang Q; Yi H; Tang S
Pharmacol Res Perspect; 2020 Dec; 8(6):e00696. PubMed ID: 33300686
[TBL] [Abstract][Full Text] [Related]
2. Analysis of IL-6, STAT3 and HSPA1L gene polymorphisms in anti-tuberculosis drug-induced hepatitis in a nested case-control study.
Wang J; Chen R; Tang S; Lv X; Wu S; Zhang Y; Xia Y; Gao P; Tu D; Chen D; Zhan S
PLoS One; 2015; 10(3):e0118862. PubMed ID: 25789467
[TBL] [Abstract][Full Text] [Related]
3. Design of the anti-tuberculosis drugs induced adverse reactions in China National Tuberculosis Prevention and Control Scheme Study (ADACS).
Xia YY; Hu DY; Liu FY; Wang XM; Yuan YL; Tu DH; Chen YX; Zhou L; Zhu LZ; Gao WW; Wang HY; Chen da F; Yang L; He PP; Li XT; He YJ; Sun F; Zhan SY
BMC Public Health; 2010 May; 10():267. PubMed ID: 20492672
[TBL] [Abstract][Full Text] [Related]
4. Impact of PD-L1 Gene Polymorphisms and Interactions with Cooking with Solid Fuel Exposure on Tuberculosis.
Tang K; Wang J; Zhong H; Wang Q; Li Z; Wu C; An R; Lin Y; Tan H; Chen L; Wang M; Chen M
Public Health Genomics; 2024; 27(1):74-82. PubMed ID: 38735285
[TBL] [Abstract][Full Text] [Related]
5. Heme Oxygenase-1 (HMOX1) Gene Polymorphisms, Thrombosis and COVID-19: Correspondence.
Mungmunpuntipantip R; Wiwanitkit V
Galen Med J; 2023; 12():1-2. PubMed ID: 38774857
[No Abstract] [Full Text] [Related]
6. Home-based Anti-Tuberculosis Treatment Adverse Reactions (HATTAR) study: a protocol for a prospective observational study.
Yang M; Pan H; Lu L; He X; Chen H; Tao B; Liu W; Yi H; Tang S
BMJ Open; 2019 Mar; 9(3):e027321. PubMed ID: 30928962
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic and toxicodynamic concepts in idiosyncratic, drug-induced liver injury.
Roth RA; Kana O; Filipovic D; Ganey PE
Expert Opin Drug Metab Toxicol; 2022; 18(7-8):469-481. PubMed ID: 36003040
[TBL] [Abstract][Full Text] [Related]
8. Amelioration of Nephrotoxicity in Mice Induced by Antituberculosis Drugs Using
Dubiwak AD; Gerema U; Abdisa D; Tofik E; Reta W
Int J Nephrol; 2022; 2022():6941509. PubMed ID: 35342648
[TBL] [Abstract][Full Text] [Related]
9. A Dual Role of Heme Oxygenase-1 in Tuberculosis.
Yang S; Ouyang J; Lu Y; Harypursat V; Chen Y
Front Immunol; 2022; 13():842858. PubMed ID: 35281042
[TBL] [Abstract][Full Text] [Related]
10. TANC1 methylation as a novel biomarker for the diagnosis of patients with anti-tuberculosis drug-induced liver injury.
Wu D; Li Y; Ren Q; Pei S; Wang L; Yang L; Chong Y; Sun S; Hao J; Feng F
Sci Rep; 2021 Aug; 11(1):17423. PubMed ID: 34465797
[TBL] [Abstract][Full Text] [Related]
11. Heme Oxygenase-1 as a Pharmacological Target for Host-Directed Therapy to Limit Tuberculosis Associated Immunopathology.
Chinta KC; Pacl HT; Agarwal A; Steyn AJC
Antioxidants (Basel); 2021 Jan; 10(2):. PubMed ID: 33530574
[TBL] [Abstract][Full Text] [Related]
12. N-Acetyl Cysteine as an Adjunct in the Treatment of Tuberculosis.
Ejigu DA; Abay SM
Tuberc Res Treat; 2020; 2020():5907839. PubMed ID: 32411461
[TBL] [Abstract][Full Text] [Related]
13. Possible association of HMOX1 and NQO1 polymorphisms with anti-tuberculosis drug-induced liver injury: A matched case-control study.
Yang M; Zhang H; Tao B; Pan H; Lu L; Yi H; Tang S
J Clin Pharm Ther; 2019 Aug; 44(4):534-542. PubMed ID: 30776144
[TBL] [Abstract][Full Text] [Related]
14. Association of ABO blood group and antituberculosis drug-induced liver injury: A case-control study from a Chinese Han population.
Tao B; Yang M; Chen H; Pan H; Liu W; Yi H; Tang S
J Clin Pharm Ther; 2020 Aug; 45(4):638-645. PubMed ID: 32259340
[TBL] [Abstract][Full Text] [Related]
15. Association between genetic polymorphisms of NRF2, KEAP1, MAFF, MAFK and anti-tuberculosis drug-induced liver injury: a nested case-control study.
Chen S; Pan H; Chen Y; Lu L; He X; Chen H; Chen R; Zhan S; Tang S
Sci Rep; 2019 Oct; 9(1):14311. PubMed ID: 31586142
[TBL] [Abstract][Full Text] [Related]
16. Association between NR1I2 polymorphisms and susceptibility to anti-tuberculosis drug-induced hepatotoxicity in an Eastern Chinese Han population: A case-control study.
Yang M; Pan H; Chen H; Liu W; Lu L; He X; Yi H; Tang S
Infect Genet Evol; 2020 Sep; 83():104349. PubMed ID: 32387752
[TBL] [Abstract][Full Text] [Related]
17. NAT2 polymorphisms and susceptibility to anti-tuberculosis drug-induced liver injury: a meta-analysis.
Wang PY; Xie SY; Hao Q; Zhang C; Jiang BF
Int J Tuberc Lung Dis; 2012 May; 16(5):589-95. PubMed ID: 22409928
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
